VASCULAR CELLULAR CONSEQUENCES OF HYPERGLYCEMIA
VASCULAR CELLULAR CONSEQUENCES OF HYPERGLYCEMIA
批准号:
6665832
负责人:
Y A IDO
金额:
$15.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2003-07-31
中文摘要
C-肽,胰岛素原加工过程中的裂解产物
胰岛素,一直被认为具有很少的生物学活性
除了参与胰岛素合成以外的其他活动。注入
预防或减弱血管和神经的人C肽
(电生理)功能障碍和Na+、K+依赖受损
糖尿病大鼠组织中三磷酸腺苷的活性。非极性
这些都需要肽中间部分的氨基酸。
生物效应。合成反向序列(追溯)和
全D-氨基酸(对映体)C-肽与天然的等效性
C-肽,提示C-肽在糖尿病中的作用
非手性介导的血管和神经功能障碍
相互作用,而不是空间特异性的受体或结合部位。
组织山梨醇水平用GC/MS测定,不受
C-肽。
英文摘要
C-peptide, a cleavage product from the processing of proinsulin to
insulin, has been considered to possess little if any biological
activity other than its participation in insulin synthesis. Injectin
of human C-peptide prevented or attenuated vascular and neural
(electrophysiological) dysfunction and impaired Na+- and K+-dependent
adenosine triphosphate activity in tissues of diabetic rats. Nonpolar
amino acids in the midportion of the peptide were required for these
biological effects. Synthetic reverse sequence (retro) and
all-D-amino acid (enantio) C-peptides were equipotent to native
C-peptide, which indicates that the effects of C-peptide on diabetic
vascular and neural dysfunction were mediated by nonchiral
interactions instead of sterospecific receptors or binding sites.
Tissue sorbitol levels were measured by GC/MS and were not affected by
C-peptide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VASCULAR CELLULAR CONSEQUENCES OF HYPERGLYCEMIA
-
批准号:6486712
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2001
-
负责人:Y A IDO
-
依托单位:
VASCULAR CELLULAR CONSEQUENCES OF HYPERGLYCEMIA
-
批准号:6336782
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2000
-
负责人:Y A IDO
-
依托单位:
PREVENTION OF VASCULAR & NEURAL DYSFUNCTION IN DIABETIC RATS BY C-PEPTIDE
-
批准号:6118528
-
项目类别:
-
资助金额:$0.08万
-
财政年份:1998
-
负责人:Y A IDO
-
依托单位:
DIABETES & SCIATIC NERVE HYPEREMIA INDUCED BY SURGICAL TRAUMA: DIAB NEUROPATHY
-
批准号:6118529
-
项目类别:
-
资助金额:$0.08万
-
财政年份:1998
-
负责人:Y A IDO
-
依托单位:
SORBITOL DEHYDROGENASE & ALDOSE REDUCTASE & NERVE CONDUCTIN IN DIABETIC RATS
-
批准号:6249784
-
项目类别:
-
资助金额:$0.42万
-
财政年份:1997
-
负责人:Y A IDO
-
依托单位: